talipexole has been researched along with levodopa in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fowler, CJ; Magnusson, O; Mohringe, B; Ogren, SO; Wijkström, A | 1 |
Fukuda, T; Irifune, M; Nomoto, M | 1 |
Yanagisawa, N | 1 |
Fukuzaki, K; Kitahara, K; Kohno, Y; Koja, T | 1 |
Dimpfel, W | 1 |
Arai, H; Hatta, K; Hattori, N; Ishikawa, K; Kamigaichi, R; Kubo, S; Mochizuki, H; Ogaki, K; Usui, C; Yokoyama, K | 1 |
Hang, TJ; Jia, L; Song, M; Wen, AD; Xu, XF; Yang, L; Zhang, TT | 1 |
Kitamura, Y | 1 |
2 review(s) available for talipexole and levodopa
Article | Year |
---|---|
[Clinical characteristics and trends in research of Parkinson's disease and parkinsonism in Japan].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azepines; Child; Child, Preschool; Disease Progression; Dopamine Agonists; Female; Humans; Infant; Japan; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease | 1997 |
[Dopaminergic neuroprotection and reconstruction of neural network tiara].
Topics: Animals; Azepines; Benzothiazoles; Brain; Dopamine; Dopamine Agonists; Embryonic Stem Cells; Humans; Levodopa; Mice; Microglia; Nerve Net; Nerve Regeneration; Neuroprotective Agents; Parkinson Disease; Planarians; Pramipexole; Rats | 2010 |
1 trial(s) available for talipexole and levodopa
Article | Year |
---|---|
Pharmacokinetic profile of talipexole in healthy volunteers is not altered when it is co-administered with Madopar (co-beneldopa).
Topics: Administration, Oral; Adult; Area Under Curve; Azepines; Benserazide; China; Chromatography, Liquid; Cross-Over Studies; Dopamine Agents; Dopamine Agonists; Drug Combinations; Drug Interactions; Female; Half-Life; Humans; Levodopa; Male; Tablets; Tandem Mass Spectrometry | 2009 |
5 other study(ies) available for talipexole and levodopa
Article | Year |
---|---|
Comparison of the effects of haloperidol, remoxipride and raclopride on "pre"- and postsynaptic dopamine receptors in the rat brain.
Topics: Adrenergic alpha-Agonists; Animals; Antipsychotic Agents; Azepines; Behavior, Animal; Benzamides; Brain; Haloperidol; Levodopa; Male; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Remoxipride; Salicylamides | 1988 |
Antiparkinsonian activity of talipexole in MPTP-treated monkeys: in combination with L-dopa and as chronic treatment.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Antiparkinson Agents; Azepines; Callithrix; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Levodopa; Male; Motor Activity; MPTP Poisoning; Parkinson Disease, Secondary | 1994 |
Anti-tremor activity of talipexole produced by selective dopamine D2 receptor stimulation in cynomolgus monkeys with unilateral lesions in the ventromedial tegmentum.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Animals; Azepines; Behavior, Animal; Bromocriptine; Dopamine Agents; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Hypnotics and Sedatives; Injections, Subcutaneous; Levodopa; Macaca fascicularis; Male; Receptors, Dopamine D2; Tegmentum Mesencephali; Tremor | 1997 |
Pharmacological modulation of dopaminergic brain activity and its reflection in spectral frequencies of the rat electropharmacogram.
Topics: Animals; Azepines; Brain; Dopamine Agents; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Electroencephalography; Levodopa; Microelectrodes; Quinpirole; Rats; Rats, Inbred F344; Receptors, Dopamine D2; Sulpiride | 2008 |
Effective control of catatonia in Parkinson's disease by electroconvulsive therapy: a case report.
Topics: Aged; Antiparkinson Agents; Azepines; Benzothiazoles; Cabergoline; Carbidopa; Catatonia; Catechols; Drug Therapy, Combination; Electroconvulsive Therapy; Ergolines; Female; Humans; Levodopa; Nitriles; Parkinson Disease; Pramipexole | 2009 |